According to the agreement, Elanco will acquire all outstanding stock of Kindred BioSciences for $9.25 per share, or approximately $440 million, a premium of 52% based on the 30-day average.
Meeting veterinarians’ needs can help practices develop happy, motivated associates.
An expert in practice management offers 4 tips to efficiently handle and increase the number of calls to your practice without compromising client service.